ARROWHEAD PHARMACEUTICALS, INC. 10-Q filing
Filed 2026-02-05 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0000879407-26-000034
- Form type
- 10-Q
- CIK
- 0000879407
- Primary document
- https://www.sec.gov/Archives/edgar/data/879407/000087940726000034/arwr-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ARROWHEAD PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $264.0M | - | - |
| Operating Income | $40.8M | - | - |
| Net Income | $30.8M | - | - |
| Eps Basic | 0.22 | - | - |
| Eps Diluted | 0.22 | - | - |
| Total Assets | $1.6B | - | - |
| Shareholders Equity | $568.4M | - | - |
| Operating Cash Flow | $13.5M | - | - |
| Capital Expenditures | $2.1M | - | - |